Insights from immuno-oncology: the Society for Immunotherapy of Cancer Statement on access to IL-6-targeting therapies for COVID-19.

Details

Ressource 1Download: 32300051_BIB_819D81E8FA74.pdf (404.41 [Ko])
State: Public
Version: Final published version
License: CC BY-NC 4.0
Serval ID
serval:BIB_819D81E8FA74
Type
Article: article from journal or magazin.
Publication sub-type
Editorial
Collection
Publications
Institution
Title
Insights from immuno-oncology: the Society for Immunotherapy of Cancer Statement on access to IL-6-targeting therapies for COVID-19.
Journal
Journal for immunotherapy of cancer
Author(s)
Ascierto P.A., Fox B., Urba W., Anderson A.C., Atkins M.B., Borden E.C., Brahmer J., Butterfield L.H., Cesano A., Chen D., de Gruijl T., Dillman R.O., Drake C.G., Emens L.A., Gajewski T.F., Gulley J.L., Stephen Hodi F., Hwu P., Kaufman D., Kaufman H., Lotze M., McNeel D.G., Margolin K., Marincola F., Mastrangelo M.J., Maus M.V., Parkinson D.R., Romero P.J., Sondel P.M., Spranger S., Sznol M., Weiner G.J., Wiggington J.M., Weber J.S.
ISSN
2051-1426 (Electronic)
ISSN-L
2051-1426
Publication state
Published
Issued date
04/2020
Peer-reviewed
Oui
Volume
8
Number
1
Language
english
Notes
Publication types: Editorial
Publication Status: ppublish
Keywords
Betacoronavirus, Coronavirus Infections/diagnostic imaging, Coronavirus Infections/drug therapy, Coronavirus Infections/immunology, Coronavirus Infections/therapy, Drug Approval, Humans, Immunologic Factors/therapeutic use, Immunotherapy, Inflammation/blood, Inflammation/therapy, Interleukin-6/agonists, Neoplasms/therapy, Pandemics, Pneumonia, Viral/diagnostic imaging, Pneumonia, Viral/drug therapy, Pneumonia, Viral/immunology, Pneumonia, Viral/therapy, Receptors, Interleukin-6/agonists, immunomodulation, inflammation mediators
Pubmed
Open Access
Yes
Create date
25/04/2020 18:59
Last modification date
15/01/2021 7:10
Usage data